Efficacy of Adjunctive Cariprazine in Patients With Major Depressive Disorder and Anxiety Symptoms: A Post Hoc Analysis

被引：0
|
作者：
Fava, Maurizio [1 ]
Maletic, Vladimir [1 ]
Chen, Chen [1 ]
Adams, Julie [1 ]
Kramer, Ken [1 ]
Kerolous, Majid [1 ]
机构：
[1] AbbVie, Madison, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷 / SUPPL 1期
关键词：
Cariprazine; Dopamine; Major Depressive Disorder; Anxiety;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P342
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [31] Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data
    Vieta, Eduard
    Mcintyre, Roger S.
    Yu, Jun
    Aronin, Lauren C.
    Kramer, Ken
    Nguyen, Huy-Binh
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 366 : 136 - 145
  • [32] Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial
    Citrome, Leslie
    Gommoll, Carl P.
    Tang, Xiongwen
    Nunez, Rene
    Mathews, Maju
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) : 75 - 81
  • [33] Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms
    Akkaya, Cengiz
    TURK PSIKIYATRI DERGISI, 2006, 17 (02) : 139 - 146
  • [34] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Hopwood, Malcolm
    NEUROLOGY AND THERAPY, 2023, 12 (SUPPL 1) : 5 - 12
  • [35] Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data
    McIntyre, Roger S.
    Therrien, Francois
    Ismail, Zahinoor
    Meehan, Stine R.
    Miguelez, Maia
    Larsen, Klaus Groes
    Chen, Dalei
    MacKenzie, Erin M.
    Thase, Michael E.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 162 : 71 - 78
  • [36] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Malcolm Hopwood
    Neurology and Therapy, 2023, 12 : 5 - 12
  • [37] Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials
    Thase, Michael E.
    Yeung, Paul P.
    Rekeda, Ludmyla
    Liu, Meng
    Varughese, Shane
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2025, 40 (01) : 27 - 36
  • [38] The efficacy of cariprazine on function in patients with bipolar depression: a post hoc analysis of a randomized controlled trial
    Vieta, Eduard
    Calabrese, Joseph R.
    Whelan, Jessica
    Tohen, Mauricio
    Earley, Willie R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1635 - 1643
  • [39] EEG coherences of the default mode network among patients comorbid with major depressive disorder and anxiety symptoms
    Ho, Sok-In
    Lin, I-Mei
    Hsieh, Jen-Chuen
    Yen, Cheng-Fang
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 361 : 728 - 738
  • [40] Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis
    Swann, Alan C.
    Fava, Maurizio
    Tsai, Joyce
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    CNS SPECTRUMS, 2017, 22 (02) : 228 - 235
12345